NZ Hepatitis Research Review Issue 40

In this issue:

Tenofovir vs entecavir for HBV-related HCC after resection
Progress towards HCV elimination in high-income countries
Vaccine regimen to prevent chronic HCV infection
Entecavir vs tenofovir for preventing HCC in chronic HBV
Transition to cirrhosis and liver cancer in Asian CHB
Metagenome-assembled genomes of gut microbiota in NAFLD
C-C chemokine receptor 9 in non-alcoholic steatohepatitis
HBcrAg assay to classify HBeAg-negative individuals
Decreased SARS-CoV-2 rates after non-COVID-19 vaccinations
EASL position paper on COVID-19 vaccines in patients with chronic  liver diseases

Please login below to download this issue (PDF)